In a tumultuous week for Brexit negotiations, top stories hitting the medical devices headlines include MedTech Europe writing to EU commissioners to highlight dangers to the industry, and a report on 10 ways we could be affected by no-deal including access to medicines. Other stories include the FDA on regulating AI in medical technology.
Interested in Star’s innovative outsourcing and resourcing solutions?
Contact Head of Business Development, Ryan Wooller, at firstname.lastname@example.org, or get in touch on 07748 464 079.
On the hunt for a new role, or just curious?
Visit our candidate page, submit your CV to email@example.com, or give our offices a ring!
NHS England has announced details of how people with Type 1 diabetes will benefit from flash glucose monitors from April 2019.
Ministers and NHS leaders say every effort is being made to ensure there will be enough medicines and clinical equipment available in the event of delays to imports from the EU.
Over the past 18 months, the US Food and Drug Administration (FDA) has faced a major challenge in updating its regulations, as a result of an influx of artificial intelligence (AI) devices set to transform healthcare.
The European Commission has revamped its medical device section on its website to include a portal that presents the new regulatory requirements targeted at impacted actors.
Industry trade association MedTech Europe has written to EU commissioners highlighting the dangers of Brexit on the medical technology sector.
While you’re here…
…and are interested in our content, why not sign up to our newsletter? It’s just below here.